The Latest Cardiac and Vascular News
COSIRA-II Trial Designed to Study the Neovasc Reducer™ for Patients with Refractory Angina VANCOUVER and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced enrollment of the first patient in the COSIRA-II clinical trial. COSIRA-II (COronary SInus Reducer for the Treatment of Refractory Angina) is a pivotal trial […]
LAGUNA HILLS, Calif., Jan. 4, 2022 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF). The cases were performed at Medicover Hospital, Warsaw, Poland by Dr. Pawel Derejko, Head […]
PLANO, Texas, Jan. 5, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics) today announced that its parent company, MEDICALgorithmics S.A. (WSE: MDG) has received a broad patent (US Patent No. 11,183,305) for continuous (full-disclosure) ECG streaming, analysis and monitoring from a remote location. “Traditional Mobile Cardiac Telemetry (MCT) devices upload […]
Amended study design provides immediate access and clinical benefits for all patients and becomes the first global IDE study for PA pressure-guided heart failure management LISLE, Ill., Jan. 5, 2022 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the […]
3D models will be used to simulate complex valve repairs in preparation for surgical interventions BOSTON, Jan. 5, 2022 /PRNewswire/ — BIOMODEX®, the leader in biorealistic haptic simulators for physician training and rehearsals, and the Montreal Heart Institute (MHI), a world-renowned, ultra-specialized cardiology center, announced they are partnering to develop a new cardiovascular training solution to […]
CAMBRIDGE, Mass., Jan. 5, 2022 /PRNewswire/ — Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced the appointment of David McIntyre as Chief Financial Officer. Mr. McIntyre will assume responsibility for the company’s finance and investor relation functions, and joins Anthos as its lead product candidate, abelacimab, expects […]
WEST CHESTER, Pa., Jan. 4, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce the final closing of their $5.95M Series A financing, which includes conversion of all existing convertible notes. The A round was led by Florida based New World Angels (https://www.newworldangels.com/), followed by DeepWork Capital (https://www.deepworkcapital.com/) and Ocean Azul Partners (https://oceanazulpartners.com/). VESTECK received significant support […]
TPG investment to fuel next stage of growth and expansion for Confluent, building on its strong foundation as a leading partner to medical device manufacturers SCOTTSDALE, Ariz. & SAN FRANCISCO–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent”), a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), today announced that […]
HOUSTON–(BUSINESS WIRE)–Saranas announces today the closing of the company’s two largest Integrated Delivery Network (IDN) contracts and agreements signed to date: CommonSpirit Health and the Department of Defense. CommonSpirit Health, encompassing all Catholic Health Initiative (CHI) and Dignity Health hospitals, has awarded Saranas a multi-year contract for the use of […]
100-patient study confirms efficiency of Upstream Peripheral’s GoBack Catheter to cross toughest peripheral vascular lesions CAESAREA, Israel & TAMPA, Fla.–(BUSINESS WIRE)–Upstream Peripheral Technologies announced today that its CTO-busting GoBack® Catheter for crossing and reentry was proven very effective for patients undergoing complex revascularizations in lower limb arteries. The findings are […]
